Research, Innovation & Impact

The MU Institutional Biosafety Committee (IBC) is appointed by the Division of Research, Innovation & Impact to oversee the campus Biosafety Program. Specific responsibilities of the committee:

• Review and recommend policies and guidelines that ensure biosafety procedures, equipment, facilities and training are appropriate for the biohazard risk.
• Perform an annual audit of the MU Biosafety Program.
• Review and approve all use of rDNA or Biosafety Level 2 or 3 materials prior to work being conducted.
• Review the EHS monitoring of Permitted Individuals and assist in resolving problems.
• Provide a campus forum for addressing issues involving biohazardous materials.

Meeting schedule and committee composition

The Institutional Biosafety Committee reviews, approves and oversees all research activities involving:

1. Recombinant or synthetic nucleic acid molecules, and/or

2. Human, animal, and plant pathogens (bacteria, virus, yeast, fungus, blood, bodily fluids, tissues, cell lines, prions and parasitic agents, etc.) including growth, manipulation and/or other handling and use in vitro or in vivo.

This process provides guidelines that ensure appropriate biosafety procedures, equipment, facilities and training are adequate in conjunction with the biohazard risk.

Meeting dates are the 3rd Thursday of the month, with protocol submission deadlines one month prior to meeting date.

Meetings are held via Zoom and start promptly at 2 pm unless otherwise noted.

** Protocol submission cutoff dates are to assure adequate time for committee review.
 

Committee organization

Chair
Roger W Stich, PhD, Professor Veterinary Pathobiology, (573) 882-3148

The IBC is comprised of the Recombinant or Nucleic Acid Molecule Research Subcommittee and the Biosafety Subcommittee.